Search Results 221-230 of 15586 for Cornea

  1. Mayo Clinic Finds Biomarker for Fuchs Dystrophy, and More

    — April 23, 2014 — Mayo Clinic ophthalmology researchers have found a likely indicator of Fuchs endothelial corneal dystrophy. Following up on a genome-wide ...

  2. Incidence of pseudophakic intraocular lens exchange increases with incidence of cataract surgery - Mayo Clinic

    Subcategories included dislocated lenses causing corneal edema or a uveitis-glaucoma-hyphema syndrome. Other major categories for intraocular lens exchange ...

  3. Sulfacetamide and prednisolone (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Make sure you tell your doctor if you have any other medical problems, especially: Cataract or; Cornea (part of the eye) problems, history of or; Glaucoma or ...

  4. Loteprednol and tobramycin (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Make sure you tell your doctor if you have any other medical problems, especially: Cataract surgery, recent or; Cornea (part of the eye) problems, history of or ...

  5. Medical Research & Education - Mayo Clinic News Network

    Reducing infection from asymptomatic COVID-19 carriers? Robert Nellis. March 11, 2021. Biotherapeutics. Regenerative approaches to improving corneal ...

  6. Brimonidine and timolol (ophthalmic route) - Mayo Clinic

    Cornea (part of the eye) problems, history of or; Depression or; Eye surgery, recent or; Heart disease or; Lung disease or; Orthostatic hypotension (dizziness ...

  7. Thyroid eye disease clinic — The Mayo Clinic Model

    The main goal is to address significant proptosis or corneal exposure, optic neuropathy and, occasionally, persistent retro-orbital pain despite other therapies ...

  8. Publications - Richard D. TenHulzen, M.D. - Mayo Clinic

    Miller DD, Wagner IV, Ten Hulzen RD, Dorairaj S, Mashayekhi A, Krambeer C, Boopathiraj N, Stewart M. Delayed Corneal Healing After the Use of Topical Ophthalmic ...

  9. Minnesota Partnership Announces Seven New Research Awards - Mayo Clinic News Network

    Corneal transplantation is the only available treatment option for this disease. With the identification of the underlying disease mechanism, researchers are ...

  10. Mayo Clinic Department of Ophthalmology - Clinical trials

    The purpose of this study is to determine visual function in patients with Fuchs Endothelial Corneal Dystrophy (FECD) to understand when in the course of ...